Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.
Schulz AS, Glatting G, Hoenig M, Schuetz C, Gatz SA, Grewendorf S, Sparber-Sauer M, Muche R, Blumstein N, Kropshofer G, Suttorp M, Bunjes D, Debatin KM, Reske SN, Friedrich W. Schulz AS, et al. Among authors: blumstein n. Blood. 2011 Apr 28;117(17):4642-50. doi: 10.1182/blood-2010-06-284349. Epub 2011 Feb 15. Blood. 2011. PMID: 21325170 Free article. Clinical Trial.
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Zenz T, Schlenk RF, Glatting G, Neumaier B, Blumstein N, Buchmann I, von Harsdorf S, Ringhoffer M, Wiesneth M, Keller F, Kotzerke J, Röttinger E, Stilgenbauer S, Döhner H, Reske SN, Bunjes D. Zenz T, et al. Among authors: blumstein n. J Nucl Med. 2006 Feb;47(2):278-86. J Nucl Med. 2006. PMID: 16455634 Free article. Clinical Trial.
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
Ringhoffer M, Blumstein N, Neumaier B, Glatting G, von Harsdorf S, Buchmann I, Wiesneth M, Kotzerke J, Zenz T, Buck AK, Schauwecker P, Stilgenbauer S, Döhner H, Reske SN, Bunjes D. Ringhoffer M, et al. Among authors: blumstein n. Br J Haematol. 2005 Aug;130(4):604-13. doi: 10.1111/j.1365-2141.2005.05663.x. Br J Haematol. 2005. PMID: 16098076 Free article. Clinical Trial.
[PET and PET/CT in relapsing prostate carcinoma].
Reske SN, Blumstein NM, Glatting G. Reske SN, et al. Among authors: blumstein nm. Urologe A. 2006 Oct;45(10):1240, 1242-4, 1246-8, 1250. doi: 10.1007/s00120-006-1212-6. Urologe A. 2006. PMID: 17006698 Review. German.
[Advancement of PET and PET/CT in prostate carcinoma].
Reske SN, Blumstein NM, Glatting G. Reske SN, et al. Among authors: blumstein nm. Urologe A. 2006 Jun;45(6):707-10, 712-4. doi: 10.1007/s00120-006-1088-5. Urologe A. 2006. PMID: 16788788 German.
Imaging prostate cancer with 11C-choline PET/CT.
Reske SN, Blumstein NM, Neumaier B, Gottfried HW, Finsterbusch F, Kocot D, Möller P, Glatting G, Perner S. Reske SN, et al. Among authors: blumstein nm. J Nucl Med. 2006 Aug;47(8):1249-54. J Nucl Med. 2006. PMID: 16883001 Free article. Clinical Trial.
36 results